This activity is part 3 in a 3-part webinar series.
Program Description
Pharmacists can be essential in managing complex medication regimens for patients with anemia in chronic kidney disease (CKD). Adverse drug reactions and drug-drug interactions can have a significant impact on costs and health care outcomes for patients and can be further exacerbated by social determinants of health affecting patients with CKD. This module will focus on biologic, socioeconomic, and demographic differences affecting patients with anemia in CKD that can impact disease progression, health literacy, and access to care. The module will also review prevention strategies pharmacists can implement within their communities and practice settings to mitigate health care disparities to improve provision of care for patients with anemia and CKD.
Target audience: Health-system, retail, and specialty pharmacists
Type of activity: Application
Release date: August 31, 2022
Expiration date: August 31, 2023
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Differentiate the health disparities in CKD and associated impact on care
- Explain the goals for addressing improved screening, early treatment, and health literacy
- Examine the challenges and barriers for patient access into pharmacist-led algorithms

Katherine H. Cho, PharmD, BCACP
Clinical Assistant professor
Department of Pharmacy Practice
Temple University School of Pharmacy
Ambulatory Care Clinical Pharmacy Specialist
Temple Internal medicine Associates
Philadelphia, Pennsylvania

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-407-H01-P. The activity is available for CE credit through August 31, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Katherine H. Cho, PharmD, BCACP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, MBA, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
